| Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer Y Zeng, RU Jin Seminars in cancer biology 86, 566-582, 2022 | 123 | 2022 |
| RAB26 and RAB3D are direct transcriptional targets of MIST1 that regulate exocrine granule maturation X Tian, RU Jin, AJ Bredemeyer, EJ Oates, KM Błażewska, CE McKenna, ... Molecular and cellular biology 30 (5), 1269-1284, 2010 | 112 | 2010 |
| The E3 ubiquitin ligase Cullin 4A regulates meiotic progression in mouse spermatogenesis Y Yin, C Lin, ST Kim, I Roig, H Chen, L Liu, GM Veith, RU Jin, S Keeney, ... Developmental biology 356 (1), 51-62, 2011 | 97 | 2011 |
| A single transcription factor is sufficient to induce and maintain secretory cell architecture HYG Lo, RU Jin, G Sibbel, D Liu, A Karki, MS Joens, BB Madison, ... Genes & development 31 (2), 154-171, 2017 | 85 | 2017 |
| RAB26 coordinates lysosome traffic and mitochondrial localization RU Jin, JC Mills Journal of Cell Science 127 (5), 1018-1032, 2014 | 49 | 2014 |
| The ubiquitin ligase Mindbomb 1 coordinates gastrointestinal secretory cell maturation BJ Capoccia, RU Jin, YY Kong, RM Peek, M Fassan, M Rugge, JC Mills The Journal of clinical investigation 123 (4), 2013 | 47 | 2013 |
| Transcriptional regulation of X-box-binding protein one (XBP1) by hepatocyte nuclear factor 4α (HNF4Α) is vital to beta-cell function BD Moore, RU Jin, H Lo, M Jung, H Wang, MA Battle, CB Wollheim, ... Journal of Biological Chemistry 291 (12), 6146-6157, 2016 | 34 | 2016 |
| The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation MT Jacobs, M Olson, BP Ferreira, R Jin, R Hachem, D Byers, C Witt, ... American Journal of Transplantation 20 (2), 589-592, 2020 | 27 | 2020 |
| Are gastric and esophageal metaplasia relatives? The case for Barrett’s stemming from SPEM RU Jin, JC Mills Digestive diseases and sciences 63, 2028-2041, 2018 | 24 | 2018 |
| FOLFIRINOX for the treatment of advanced gastroesophageal cancers: a phase 2 nonrandomized clinical trial H Park, RU Jin, A Wang-Gillam, R Suresh, C Rigden, M Amin, BR Tan, ... JAMA oncology 6 (8), 1231-1240, 2020 | 23 | 2020 |
| The cyclical hit model: how paligenosis might establish the mutational landscape in Barrett's esophagus and esophageal adenocarcinoma RU Jin, JC Mills Current opinion in gastroenterology 35 (4), 363-370, 2019 | 23 | 2019 |
| Gastric organoids: progress and remaining challenges MJ Pang, JR Burclaff, R Jin, M Adkins-Threats, LH Osaki, Y Han, JC Mills, ... Cellular and Molecular Gastroenterology and Hepatology 13 (1), 19-33, 2022 | 20 | 2022 |
| Cellular plasticity at the nexus of development and disease LB Spatz, RU Jin, JC Mills Development 148 (3), dev197392, 2021 | 12 | 2021 |
| Tropism of severe acute respiratory syndrome coronavirus 2 for barrett’s esophagus may increase susceptibility to developing coronavirus disease 2019 RU Jin, JW Brown, QK Li, PO Bayguinov, JS Wang, JC Mills Gastroenterology 160 (6), 2165-2168. e4, 2021 | 11 | 2021 |
| Identification of alanyl aminopeptidase (CD13) as a surface marker for isolation of mature gastric zymogenic chief cells BD Moore, RU Jin, L Osaki, J Romero-Gallo, J Noto, RM Peek Jr, JC Mills American Journal of Physiology-Gastrointestinal and Liver Physiology 309 (12 …, 2015 | 11 | 2015 |
| Tumor organoids to study gastroesophageal cancer: a primer RU Jin, JC Mills Journal of Molecular Cell Biology 12 (8), 593-606, 2020 | 9 | 2020 |
| Molecular pathology of gastroesophageal cancer MD Stachler, RU Jin Surgical Pathology Clinics 14 (3), 443-453, 2021 | 8 | 2021 |
| Shared features of metaplasia and the development of adenocarcinoma in the stomach and esophagus Y Zeng, QK Li, S Roy, JC Mills, RU Jin Frontiers in Cell and Developmental Biology 11, 1151790, 2023 | 6 | 2023 |
| The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer Y Zeng, AC Lockhart, RU Jin Expert Opinion on Drug Discovery 19 (8), 873-886, 2024 | 2 | 2024 |
| Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Final analysis of a phase II trial. H Park, A Sanjeevaiah, PJ Hosein, R Mehta, R Jin, P Grierson, R Suresh, ... Journal of Clinical Oncology 40 (4_suppl), 284-284, 2022 | 2 | 2022 |
